Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 3, 2011, Pages 743-751

  Lee, Su Jin ^a   Choi, Yoon La ^a   Park, Yeon Hee ^a   Kim, Seung Tae ^a   Cho, Eun Yoon ^a   Ahn, Jin Seok ^a   Im, Young Hyuck ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Capecitabine; Immunohistochemistry; Metastatic breast cancer; Thymidine phosphorylase; Thymidylate synthase

Indexed keywords

ANTHRACYCLINE; CAPECITABINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ADULT; AGE; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW METASTASIS; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CONTROL; DRUG DOSE REDUCTION; DRUG RESPONSE; HAND FOOT SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MONOTHERAPY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SKIN METASTASIS; SOFT TISSUE METASTASIS; TREATMENT DURATION; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; COHORT STUDIES; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TAXOIDS; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 80053932095     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1545-0     Document Type: Article

References (31)

1. Blum JL (1999) Xeloda in the treatment of metastatic breast cancer. Oncology 57(Suppl 1):16-20
2. JL Blum V Dieras PM Lo Russo J Horton O Rutman A Buzdar B Osterwalder 2001 Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients Cancer 92 1759 1768 11745247 10.1002/1097- 0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A 1:CAS:528: DC%2BD3MXosV2qsLw%3D
3. JL Blum SE Jones AU Buzdar PM LoRusso I Kuter C Vogel B Osterwalder HU Burger CS Brown T Griffin 1999 Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer J Clin Oncol 17 485 493 10080589 1:CAS:528:DyaK1MXht1Wmurw%3D
4. P Fumoleau R Largillier C Clippe V Dieras H Orfeuvre T Lesimple S Culine B Audhuy D Serin H Cure E Vuillemin JF Morere F Montestruc Z Mouri M Namer 2004 Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer Eur J Cancer 40 536 542 14962720 10.1016/j.ejca.2003.11.007 1:CAS:528:DC%2BD2cXhtFWjsbc%3D
5. AJ Wagstaff T Ibbotson KL Goa 2003 Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer Drugs 63 217 236 12515569 10.2165/00003495-200363020-00009 1:CAS:528:DC%2BD3sXhsFCjsLc%3D
6. SB Fox A Moghaddam M Westwood H Turley R Bicknell KC Gatter AL Harris 1995 Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study J Pathol 176 183 190 7636628 10.1002/path.1711760212 1:CAS:528:DyaK2MXnt1Cht7w%3D
7. DR Budman NJ Meropol B Reigner PJ Creaven SM Lichtman E Berghorn J Behr RJ Gordon B Osterwalder T Griffin 1998 Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine J Clin Oncol 16 1795 1802 9586893 1:CAS:528:DyaK1cXjtFOqs7s%3D
8. T Ishikawa F Sekiguchi Y Fukase N Sawada H Ishitsuka 1998 Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts Cancer Res 58 685 690 9485021 1:CAS:528:DyaK1cXht1antbc%3D
9. T Ishikawa M Utoh N Sawada M Nishida Y Fukase F Sekiguchi H Ishitsuka 1998 Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts Biochem Pharmacol 55 1091 1097 9605432 10.1016/S0006-2952(97)00682-5 1:CAS:528:DyaK1cXitlSiurk%3D
10. S Popat A Matakidou RS Houlston 2004 Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis J Clin Oncol 22 529 536 14752076 10.1200/JCO.2004.05.064 1:CAS:528:DC%2BD2cXptlCrs74%3D
11. S Liekens A Bronckaers MJ Perez-Perez J Balzarini 2007 Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy Biochem Pharmacol 74 1555 1567 17572389 10.1016/j.bcp.2007.05.008 1:CAS:528:DC%2BD2sXht1aktrvJ
12. Puglisi F, Cardellino GG, Crivellari D, Di Loreto C, Magri MD, Minisini AM, Mansutti M, Andreetta C, Russo S, Lombardi D, Perin T, Damante G, Veronesi A. (2008) Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer. Ann Oncol 19:1541-1556 (Epub 2008 Apr 25)
13. C Aschele D Debernardis R Bandelloni S Cascinu V Catalano P Giordani S Barni D Turci G Drudi S Lonardi L Gallo F Maley S Monfardini 2002 Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil Ann Oncol 13 1882 1892 12453856 10.1093/annonc/mdf327 1:STN:280:DC%2BD38nptF2nug%3D%3D
14. C Aschele D Debernardis S Casazza G Antonelli G Tunesi C Baldo R Lionetto F Maley A Sobrero 1999 Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy J Clin Oncol 17 1760 1770 10561213 1:CAS:528:DyaK1MXktV2qtLY%3D
15. S Cascinu C Aschele S Barni D Debernardis C Baldo G Tunesi V Catalano MP Staccioli A Brenna P Muretto G Catalano 1999 Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil Clin Cancer Res 5 1996 1999 10473077 1:STN:280:DyaK1MvgtVSmtA%3D%3D
16. DC Corsi M Ciaparrone G Zannoni M Mancini A Cassano M Specchia C Pozzo M Martini C Barone 2002 Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer Eur J Cancer 38 527 534 11872345 10.1016/S0959-8049(01)00402-6 1:CAS:528:DC%2BD38XhsFagsr0%3D
17. PG Johnston R Mick W Recant KA Behan ME Dolan MJ Ratain E Beckmann RR Weichselbaum CJ Allegra EE Vokes 1997 Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer J Natl Cancer Inst 89 308 313 9048835 10.1093/jnci/89.4.308 1:CAS:528:DyaK2sXhvVegsLs%3D
18. T Tominaga M Toi Y Ohashi O Abe 2002 Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients Clin Breast Cancer 3 55 64 12020396 10.3816/CBC.2002.n.012 1:CAS:528: DC%2BD38Xns1Wju7k%3D
19. M Toi M Atiqur Rahman H Bando LW Chow 2005 Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment Lancet Oncol 6 158 166 15737832 10.1016/S1470-2045(05)01766-3 1:CAS:528:DC%2BD2MXhslChurs%3D
20. YC Hu RA Komorowski S Graewin G Hostetter OP Kallioniemi HA Pitt SA Ahrendt 2003 Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer Clin Cancer Res 9 4165 4171 14519641 1:CAS:528:DC%2BD3sXns1Ojtbs%3D
21. Siva M, Correa P, Skaria S, Canney P (2008) Capecitabine in advanced breast cancer: predictive factors for response. J Clin Oncol 26:72S (Abstr 1126)
22. Muss HB, Berry DL, Cirrincione C, Theodoulou M, Mauer A, Cohen H, Partridge AH, Norton L, Hudis CA, Winer EP, North American Breast Cancer InIntergroup (2008) Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: results of CALGB/CTSU 49907. J Clin Oncol 26:8S (Abstr 507)
23. M Ciaparrone M Quirino G Schinzari G Zannoni DC Corsi FM Vecchio A Cassano G La Torre C Barone 2006 Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil Oncology 70 366 377 17179731 10.1159/000098110 1:CAS:528:DC%2BD2sXisFWmsw%3D%3D
24. H Li Z Suo Y Zhang B Risberg MG Karlsson K Villman JM Nesland 2004 The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas Histol Histopathol 19 129 136 14702180 1:CAS:528:DC%2BD2cXjtFyrtLs%3D
25. NJ Meropol PJ Gold RB Diasio M Andria M Dhami T Godfrey AJ Kovatich KA Lund E Mitchell R Schwarting 2006 Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer J Clin Oncol 24 4069 4077 16943524 10.1200/JCO.2005.05.2084 1:CAS:528:DC%2BD28XhtVantb3N
26. Van Cutsem E, Cunningham D, Hoff PM, Maroun J (2001) Thymidine phosphorylase (TP) activation: convenience through innovation. Oncologist 6 (suppl 4):1-2
27. Q Yang M Barbareschi I Mori F Mauri M Muscara M Nakamura Y Nakamura G Yoshimura T Sakurai O Caffo E Galligioni P Dalla Palma K Kakudo 2002 Prognostic value of thymidine phosphorylase expression in breast carcinoma Int J Cancer 97 512 517 11802215 10.1002/ijc.1633 1:CAS:528:DC%2BD38XkvFentA%3D%3D
28. F Puglisi C Andreetta F Valent AM Minisini E Rijavec S Russo M Mansutti G Cardellino S Pizzolitto C Di Loreto 2007 Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells Anticancer Drugs 18 883 888 17667593 1:CAS:528:DC%2BD2sXotlensbY%3D
29. M Toi H Bando S Horiguchi M Takada A Kataoka T Ueno S Saji M Muta N Funata S Ohno 2004 Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer Br J Cancer 90 2338 2343 15150550 1:CAS:528:DC%2BD2cXks1ahtrk%3D
30. Andreetta C, Puppin C, Minisini A, Valent F, Pegolo E, Damate G, Di Loreto C, Pizzolitto S, Pandolfi M, Fasola G, Piga A, Puglish F (2009) Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Ann Oncol 20:265-271 (Epub 2008 Sep 2)
31. U McDermott J Settleman 2009 Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology J Clin Oncol 27 5650 5659 19858389 10.1200/JCO.2009.22.9054 1:CAS:528:DC%2BC3cXhtVWit7c%3D